IV midazolam is one of 3 small molecule programs targeting Extracorporeal Shockwave Lithotripsy. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
2 competitors in Extracorporeal Shockwave Lithotripsy
IV Acetaminophen
IV Ketorolac
IV midazolam
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details